Using translational in vitro-in vivo modeling to improve drug repurposing outcomes for inhaled COVID-19 therapeutics
Madison Stoddard, Lin Yuan, Arijit Chakravarty
doi: https://doi.org/10.1101/2021.03.11.21253375
Madison Stoddard
1Fractal Therapeutics Inc, Cambridge, MA, USA
Lin Yuan
1Fractal Therapeutics Inc, Cambridge, MA, USA
Arijit Chakravarty
1Fractal Therapeutics Inc, Cambridge, MA, USA

Data Availability
The work describes a mathematical methodology based on publicly available data. All data used in the work was sourced from prior publications.
Posted March 12, 2021.
Using translational in vitro-in vivo modeling to improve drug repurposing outcomes for inhaled COVID-19 therapeutics
Madison Stoddard, Lin Yuan, Arijit Chakravarty
medRxiv 2021.03.11.21253375; doi: https://doi.org/10.1101/2021.03.11.21253375
Subject Area
Subject Areas
- Addiction Medicine (269)
- Allergy and Immunology (552)
- Anesthesia (135)
- Cardiovascular Medicine (1752)
- Dermatology (173)
- Emergency Medicine (312)
- Epidemiology (10796)
- Gastroenterology (587)
- Genetic and Genomic Medicine (2946)
- Geriatric Medicine (287)
- Health Economics (533)
- Health Informatics (1925)
- Health Policy (836)
- Hematology (291)
- HIV/AIDS (630)
- Medical Education (299)
- Medical Ethics (86)
- Nephrology (324)
- Neurology (2796)
- Nursing (151)
- Nutrition (433)
- Oncology (1463)
- Ophthalmology (444)
- Orthopedics (172)
- Otolaryngology (255)
- Pain Medicine (190)
- Palliative Medicine (56)
- Pathology (380)
- Pediatrics (866)
- Primary Care Research (337)
- Public and Global Health (5363)
- Radiology and Imaging (1011)
- Respiratory Medicine (726)
- Rheumatology (330)
- Sports Medicine (278)
- Surgery (327)
- Toxicology (47)
- Transplantation (150)
- Urology (125)